Related references
Note: Only part of the references are listed.Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer's disease
Monika Renuka Sanotra et al.
ALZHEIMERS RESEARCH & THERAPY (2023)
The heritability of amyloid burden in older adults: the Older Australian Twins Study
Rebecca Koncz et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)
Acrolein, an endogenous aldehyde induces Alzheimer's disease-like pathologies in mice: A new sporadic AD animal model
Chen Chen et al.
PHARMACOLOGICAL RESEARCH (2022)
Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics
Lucia Migliore et al.
NATURE REVIEWS NEUROLOGY (2022)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models
Ming Chen et al.
MOLECULAR NEURODEGENERATION (2021)
White matter hyperintensities and patterns of atrophy in early onset Alzheimer?s disease with causative gene mutations
Chenhui Mao et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
2021 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2021)
Advance of sporadic Alzheimer's disease animal models
Lili Zhang et al.
MEDICINAL RESEARCH REVIEWS (2020)
Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases
Md Ataur Rahman et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Leveraging preclinical models for the development of Alzheimer disease therapeutics
Kimberly Scearce-Levie et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Immune Response Mechanisms against AAV Vectors in Animal Models
Ashley T. Martino et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
The SIGMA rat brain templates and atlases for multimodal MRI data analysis and visualization
D. A. Barriere et al.
NATURE COMMUNICATIONS (2019)
Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease
Han-Hsing Tsou et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
Data-driven models of dominantly-inherited Alzheimer's disease progression
Neil P. Oxtoby et al.
BRAIN (2018)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A. Gordon et al.
LANCET NEUROLOGY (2018)
White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes
Sara E. Nasrabady et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories
Marina Avila-Villanueva et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
beta APP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease
Mickael Audrain et al.
CEREBRAL CORTEX (2018)
Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity
Flavio Giordano et al.
EPILEPSIA (2017)
Brain atrophy in Alzheimer's Disease and aging
Lorenzo Pini et al.
AGEING RESEARCH REVIEWS (2016)
Evaluation of dementia by acrolein, amyloid-β and creatinine
Kazuei Igarashi et al.
CLINICA CHIMICA ACTA (2015)
Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias
Ilya M. Nasrallah et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito et al.
NATURE NEUROSCIENCE (2014)
Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study
Pearl Behl et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Brain Microstructure Reveals Early Abnormalities more than Two Years prior to Clinical Progression from Mild Cognitive Impairment to Alzheimer's Disease
Gwenaelle Douaud et al.
JOURNAL OF NEUROSCIENCE (2013)
Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo
Ying-Juan Huang et al.
TOXICOLOGY LETTERS (2013)
Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice
Sanjay Srivastava et al.
ATHEROSCLEROSIS (2011)
Sex differences in grey matter atrophy patterns among AD and aMCI patients: Results from ADNI
Martha Skup et al.
NEUROIMAGE (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Potential Role of Acrolein in Neurodegeneration and in Alzheimers Disease
Dang Thanh Nam et al.
Current Molecular Pharmacology (2010)
MRI and CSF biomarkers in normal, MCI, and AD subjects Predicting future clinical change
P. Vemuri et al.
NEUROLOGY (2009)
Acrolein environmental levels and potential for human exposure
O. Faroon et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2008)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging
JLR Andersson et al.
NEUROIMAGE (2003)
Lipid peroxidation in aging brain and Alzheimer's disease
TJ Montine et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)